ES2052181T3 - Derivados de 2-oxo-1-oxa-8-azaespiro(4,5)decano, procesos para su preparacion y composiciones farmaceuticas de los mismos. - Google Patents

Derivados de 2-oxo-1-oxa-8-azaespiro(4,5)decano, procesos para su preparacion y composiciones farmaceuticas de los mismos.

Info

Publication number
ES2052181T3
ES2052181T3 ES90308785T ES90308785T ES2052181T3 ES 2052181 T3 ES2052181 T3 ES 2052181T3 ES 90308785 T ES90308785 T ES 90308785T ES 90308785 T ES90308785 T ES 90308785T ES 2052181 T3 ES2052181 T3 ES 2052181T3
Authority
ES
Spain
Prior art keywords
group
oxa
oxo
processes
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90308785T
Other languages
English (en)
Inventor
Edit Toth
Jozsef Torley
Bela Dr Hegedus
Laszlo Dr Szporny
Bela Kiss
Eva Dr Palosi
Dora Dr Groo
Istvan Dr Laszlovszky
Erzsebet Dr Lapis
Adam Dr Sarkadi
Andras Dr Ambrus
Judit Dr Laszy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Richter Gedeon Vegyeszeti Gyar RT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Vegyeszeti Gyar RT
Application granted granted Critical
Publication of ES2052181T3 publication Critical patent/ES2052181T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA INVENCION EXPONE UNOS DERIVADOS 2-OXO-1-OXA-8-AZASPIRO(4,5)DECANO DE FORMULA (I); EN LA QUE X REPRESENTA UN ATOMO DE OXIGENO O UN GRUPO NR DONDE R REPRESENTA UN ATOMO DE HIDROGENO O UN GRUPO ALQUILO C1-12 O CICLOALQUILO C3-6, NO CARBOCICLICO C6-10 ARILO O UN GRUPO CARBOCICLICO C6-10 ARILO-C1-4 ALQUILO SUSTITUIDO OPCIONALMENTE EN EL ANILLO AROMATICO POR UNO O MAS ATOMOS HALOGENOS, O GRUPOS ALQUILO C1-4 O ALCOXI C1-4; R1 Y R2 JUNTOS REPRESENTAN UN GRUPO METILENO O CUANDO X ES UN GRUPO >NR, UNO DE LOS R1 Y R2 PUEDE REPRESENTAR ADICIONALMENTE UN GRUPO HIDROXIL Y EL OTRO UN GRUPO METIL; Z REPRESENTA UN ATOMO DE HIDROGENO O HALOGENO O UN GRUPO TRIHALOMETIL O UNO ALCANOIL C2-4; Y N ES 2 O 3; Y TODOS LOS ISOMEROS OPTICOS Y SUS MEZCLAS Y TODAS SUS SALES DE AMERICIO CUATERNARIAS Y LAS DE ADICION ACIDA. LA INVENCION EXPONE ADEMAS, LAS COMPOSICIONES FARMACEUTICAS QUE CONTIENEN A ESOS COMPONENTES Y EL PROCESO PARA SU PREPARACION. LOS COMPONENTES DE FORMULA (I) POSEEN PROPIEDADES PSICOTROPICAS Y ANTIALERGICAS Y UNA BAJA TOXICIDAD. ADEMAS, PUEDEN SE UTILES PARA EL TRATAMIENTO DE ENFERMEDADES PSIQUIATRICAS Y ALERGICAS.
ES90308785T 1989-08-10 1990-08-09 Derivados de 2-oxo-1-oxa-8-azaespiro(4,5)decano, procesos para su preparacion y composiciones farmaceuticas de los mismos. Expired - Lifetime ES2052181T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU894093A HU204529B (en) 1989-08-10 1989-08-10 Process for producing new 1-oxa-2-oxo-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
ES2052181T3 true ES2052181T3 (es) 1994-07-01

Family

ID=10966862

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90308785T Expired - Lifetime ES2052181T3 (es) 1989-08-10 1990-08-09 Derivados de 2-oxo-1-oxa-8-azaespiro(4,5)decano, procesos para su preparacion y composiciones farmaceuticas de los mismos.

Country Status (13)

Country Link
EP (1) EP0414422B1 (es)
JP (1) JPH0377885A (es)
KR (1) KR950001022B1 (es)
AT (1) ATE103921T1 (es)
AU (1) AU623545B2 (es)
DD (1) DD299427A5 (es)
DE (1) DE69007905T2 (es)
DK (1) DK0414422T3 (es)
ES (1) ES2052181T3 (es)
HU (1) HU204529B (es)
IL (1) IL95321A (es)
NZ (1) NZ234845A (es)
ZA (1) ZA906301B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU204530B (en) * 1989-08-10 1992-01-28 Richter Gedeon Vegyeszet Process for producing new 1-oxa-2-oxo-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them
HU204054B (en) * 1989-08-10 1991-11-28 Richter Gedeon Vegyeszet Process for producing new 1-oxa-2-oxo-8-azaspiro(4,5)decane derivatives and pharmaceutical compositions comprising same
YU150489A (sh) * 1989-08-10 1992-12-21 W.L. Gore & Co. Gmbh. Uređaj za ispitivanje odevnih predmeta na nepromočivost
KR940003491B1 (ko) * 1989-08-10 1994-04-23 리히터 게데온 베기에스제티 기아르 알.티 4,4-이중 치환된 피페리딘 유도체와 그 제조방법 및 상기 화합물을 함유하는 약제학적 조성물
FR2691459B1 (fr) * 1992-05-25 1995-06-09 Adir Nouveaux derives de la phenothiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
WO2001034119A2 (en) 1999-11-12 2001-05-17 Abbott Laboratories Inhibitors of crystallization in a solid dispersion
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
CN102176190A (zh) 2003-09-26 2011-09-07 索尼计算机娱乐公司 便携式电子装置
AU2005211499A1 (en) 2004-02-10 2005-08-18 F. Hoffmann-La Roche Ag Chemokine CCR5 receptor modulators
CN101646679A (zh) 2007-03-29 2010-02-10 弗·哈夫曼-拉罗切有限公司 杂环抗病毒化合物
WO2019195789A1 (en) 2018-04-06 2019-10-10 Camp4 Therapeutics Corporation Phenothiazine derivatives and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1256404A (en) * 1968-06-07 1971-12-08 Dainippon Pharmaceutical Co 0-oxa-3,8-diazaspiro(4,5)decan-2,4-diones
DE2118339A1 (de) * 1971-04-15 1972-10-26 Yoshitomi Pharmaceutical Industries Ltd, Osaka (Japan) Pipendinspiroverbindungen
US4255432A (en) * 1979-09-06 1981-03-10 Syntex (U.S.A.) Inc. 8-[2-3-Indolyl)ethyl]-1-oxa-3-,8-diazaspiro[4.5]decan-2-ones, pharmaceutical compositions thereof and methods of use thereof
FR2615515B1 (fr) * 1987-05-22 1989-06-30 Adir Nouveaux derives du spiro 4, 5 decane, leur procede de preparation et les compositions pharmaceutiques les renfermant
YU150489A (sh) * 1989-08-10 1992-12-21 W.L. Gore & Co. Gmbh. Uređaj za ispitivanje odevnih predmeta na nepromočivost

Also Published As

Publication number Publication date
HU204529B (en) 1992-01-28
KR910004633A (ko) 1991-03-29
ATE103921T1 (de) 1994-04-15
ZA906301B (en) 1991-06-26
AU623545B2 (en) 1992-05-14
EP0414422A3 (en) 1991-07-24
NZ234845A (en) 1992-03-26
DD299427A5 (de) 1992-04-16
AU6080290A (en) 1991-02-14
IL95321A0 (en) 1991-06-30
JPH0377885A (ja) 1991-04-03
DE69007905D1 (de) 1994-05-11
EP0414422B1 (en) 1994-04-06
KR950001022B1 (ko) 1995-02-07
EP0414422A2 (en) 1991-02-27
HUT55784A (en) 1991-06-28
IL95321A (en) 1994-02-27
DE69007905T2 (de) 1994-07-21
DK0414422T3 (da) 1994-05-16

Similar Documents

Publication Publication Date Title
ATE110075T1 (de) 1,2-benzisoxazolderivate, verfahren zu deren herstellung, und sie enthaltende pharmazeutische zusammensetzungen.
ES2052181T3 (es) Derivados de 2-oxo-1-oxa-8-azaespiro(4,5)decano, procesos para su preparacion y composiciones farmaceuticas de los mismos.
IT1229570B (it) Derivati fluorurati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono.
DE3882438D1 (de) Alkansulfonanilid-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
HUT58269A (en) Process for producing aralkyl-amine derivatives and pharmaceutical compositions containing them as active components
ES2052180T3 (es) Derivados de 1-oxa-2-oxo-8-azaespiro(4,5)decano, procesos para su preparacion y composiciones farmaceuticas de los mismos.
ES2062386T3 (es) Derivados de 2-oxo-1-oxa-8-azaespiro(4,5)decano, procesos para su preparacion y composiciones farmaceuticas de los mismos.
HUT53089A (en) Process for producing cyclic guanidine derivatives of calcium-antagonistic activity and pharmaceutical compositions containing them
ATE36154T1 (de) 4-phenylaminopyridin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 414422

Country of ref document: ES